Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)-Reference-Cited by-同舟云学术

Long-term safety and tolerability of apremilast in patients with psoriasis: Pooled safety analysis for ≥156 weeks from 2 phase 3, randomized, controlled trials (ESTEEM 1 and 2)

Published:2017-08 Issue:2 Volume:77 Page:310-317.e1
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Crowley Jeffrey,Thaçi Diamant,Joly Pascal,Peris Ketty,Papp Kim A.,Goncalves Joana,Day Robert M.,Chen Rongdean,Shah Kamal,Ferrándiz Carlos,Cather Jennifer C.

Publisher

Elsevier BV

Subject

Dermatology

Reference30 articles.

1. Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination surveys;Helmick;Am J Prev Med,2014

2. Psoriasis prevalence among adults in the United States;Rachakonda;J Am Acad Dermatol,2014

3. Global epidemiology of psoriasis: a systematic review of incidence and prevalence;Parisi;J Invest Dermatol,2013

4. Patient preferences for psoriasis treatments: process characteristics can outweigh outcome attributes;Schaarschmidt;Arch Dermatol,2011

5. Patient perspectives on psoriasis management: U.S. results of the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey;Lebwohl;Psoriasis Forum,2014

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis reactivation following apremilast therapy for psoriasis: Time to consider routine TB screening?;Australasian Journal of Dermatology;2024-09-11

2. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

3. Oral Psoriasis Therapies;Dermatologic Clinics;2024-07

4. Management of Psoriasis Patients with Serious Infectious Diseases;Advances in Therapy;2024-05-06

5. Small Molecules in the Management of Psoriasis and Psoriatic Arthritis;Indian Journal of Dermatology;2024-05